Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 446

1.

Sample size calculations for clinical trials targeting tauopathies: a new potential disease target.

Whitwell JL, Duffy JR, Strand EA, Machulda MM, Tosakulwong N, Weigand SD, Senjem ML, Spychalla AJ, Gunter JL, Petersen RC, Jack CR Jr, Josephs KA.

J Neurol. 2015 Jun 17. [Epub ahead of print]

PMID:
26076744
2.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jun;11(6):e1-e120. doi: 10.1016/j.jalz.2014.11.001.

PMID:
26073027
3.

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.

Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D.

Neurology. 2015 Jun 10. pii: 10.1212/WNL.0000000000001702. [Epub ahead of print]

PMID:
26062630
4.

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.

Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR Jr, Beckett LA, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Alzheimers Dement. 2015 May 7. pii: S1552-5260(15)00124-7. doi: 10.1016/j.jalz.2015.03.003. [Epub ahead of print]

PMID:
25960448
5.

Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.

Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, Brown P, Ravenscroft T, van Blitterswijk M, Nicholson AM, DeTure M, Knopman DS, Josephs KA, Parisi JE, Petersen RC, Boylan KB, Boeve BF, Graff-Radford NR, Veltman JA, Gilissen C, Murray ME, Dickson DW, Rademakers R.

Acta Neuropathol. 2015 Jul;130(1):77-92. doi: 10.1007/s00401-015-1436-x. Epub 2015 May 6.

PMID:
25943890
6.

New criteria for Alzheimer's disease: which, when and why?

Schott JM, Petersen RC.

Brain. 2015 May;138(Pt 5):1134-7. doi: 10.1093/brain/awv055. No abstract available.

PMID:
25907755
7.

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.

Sevlever D, Zou F, Ma L, Carrasquillo S, Crump MG, Culley OJ, Hunter TA, Bisceglio GD, Younkin L, Allen M, Carrasquillo MM, Sando SB, Aasly JO, Dickson DW, Graff-Radford NR, Petersen RC; Kevin Morgan for ARUK consortium, Belbin O.

Mol Neurodegener. 2015 Apr 9;10:18. doi: 10.1186/s13024-015-0015-x.

8.

White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.

Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Gunter JL, Senjem ML, Ferman TJ, Smith GE, Geda YE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

Neurobiol Aging. 2015 Jun;36(6):2010-7. doi: 10.1016/j.neurobiolaging.2015.03.007. Epub 2015 Mar 14.

PMID:
25863527
9.

Performance of the CogState computerized battery in the Mayo Clinic Study on Aging.

Mielke MM, Machulda MM, Hagen CE, Edwards KK, Roberts RO, Pankratz VS, Knopman DS, Jack CR Jr, Petersen RC.

Alzheimers Dement. 2015 Apr 6. pii: S1552-5260(15)00086-2. doi: 10.1016/j.jalz.2015.01.008. [Epub ahead of print]

PMID:
25858683
10.

Direct medical costs and source of cost differences across the spectrum of cognitive decline: A population-based study.

Leibson CL, Long KH, Ransom JE, Roberts RO, Hass SL, Duhig AM, Smith CY, Emerson JA, Pankratz VS, Petersen RC.

Alzheimers Dement. 2015 Apr 6. pii: S1552-5260(15)00085-0. doi: 10.1016/j.jalz.2015.01.007. [Epub ahead of print]

PMID:
25858682
11.

Risk and protective factors for cognitive impairment in persons aged 85 years and older.

Roberts RO, Cha RH, Mielke MM, Geda YE, Boeve BF, Machulda MM, Knopman DS, Petersen RC.

Neurology. 2015 May 5;84(18):1854-61. doi: 10.1212/WNL.0000000000001537. Epub 2015 Apr 8.

PMID:
25854867
12.

The Human Alzheimer Disease Project: A New Call to Arms.

Rosenberg RN, Petersen RC.

JAMA Neurol. 2015 Jun 1;72(6):626-8. doi: 10.1001/jamaneurol.2015.67. No abstract available.

PMID:
25844883
13.

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.

Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR Jr, Dickson DW.

Brain. 2015 May;138(Pt 5):1370-81. doi: 10.1093/brain/awv050. Epub 2015 Mar 23.

14.

Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease.

Vemuri P, Senjem ML, Gunter JL, Lundt ES, Tosakulwong N, Weigand SD, Borowski BJ, Bernstein MA, Zuk SM, Lowe VJ, Knopman DS, Petersen RC, Fox NC, Thompson PM, Weiner MW, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jun;113:61-9. doi: 10.1016/j.neuroimage.2015.03.026. Epub 2015 Mar 20.

15.

Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.

Pankratz VS, Roberts RO, Mielke MM, Knopman DS, Jack CR Jr, Geda YE, Rocca WA, Petersen RC.

Neurology. 2015 Apr 7;84(14):1433-42. doi: 10.1212/WNL.0000000000001437. Epub 2015 Mar 18.

PMID:
25788555
16.

Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, Gregg BE, Pankratz VS, Rocca WA, Petersen RC.

JAMA Neurol. 2015 May 1;72(5):511-9. doi: 10.1001/jamaneurol.2014.4821.

PMID:
25775353
17.

Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging.

Vassilaki M, Cha RH, Aakre JA, Therneau TM, Geda YE, Mielke MM, Knopman DS, Petersen RC, Roberts RO.

J Alzheimers Dis. 2015;45(4):1237-45. doi: 10.3233/JAD-143078.

18.

Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.

Whitwell JL, Boeve BF, Weigand SD, Senjem ML, Gunter JL, Baker MC, DeJesus-Hernandez M, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA.

Eur J Neurol. 2015 May;22(5):745-52. doi: 10.1111/ene.12675. Epub 2015 Feb 12.

PMID:
25683866
19.

Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.

Pink A, Stokin GB, Bartley MM, Roberts RO, Sochor O, Machulda MM, Krell-Roesch J, Knopman DS, Acosta JI, Christianson TJ, Pankratz VS, Mielke MM, Petersen RC, Geda YE.

Neurology. 2015 Mar 3;84(9):935-43. doi: 10.1212/WNL.0000000000001307. Epub 2015 Feb 4.

PMID:
25653291
20.

Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.

Whitwell JL, Kantarci K, Weigand SD, Lundt ES, Gunter JL, Duffy JR, Strand EA, Machulda MM, Spychalla AJ, Drubach DA, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA.

J Alzheimers Dis. 2015;45(4):1109-17. doi: 10.3233/JAD-142628.

PMID:
25649655
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk